IN BRIEF
Kohl's to hold job fairs for three valley stores
Kohl's Corp., a Menomonee Falls, Wis., department store operator, will hold job fairs Sunday through Thursday to find 450 workers for three Southern Nevada stores opening in September.
In a statement, the company said jobs are open in customer service, department service, cash-register operation, early morning stocking, truck unloading, housekeeping and evening sign/pricing updates.
Interviews for a forthcoming Henderson store will run at the Hampton Inn & Suites St. Rose, 3245 St. Rose Parkway. Interviews for a forthcoming Nellis Crossing Store will run at the Eastside Cannery, 5255 Boulder Highway. Interviews for a forthcoming southwest Las Vegas store will run at the Hampton Inn & Suites Red Rock, 4280 S. Grand Canyon Drive. Fair times are 10:45 a.m. to 6:15 p.m. Sunday; 10:45 a.m. to 6:15 p.m. Monday; 12:15 p.m. to 7:30 p.m. Tuesday; 8:45 a.m. to 4 p.m. Wednesday; and 12:15 p.m. to 7:30 p.m. Thursday.
Applicants can visit www.kohlscareers.com or call 877-639-5645 to schedule interviews or get more information.
MGM Mirage job cuts equate to 14 percent
Casino operator MGM Mirage said it cut the equivalent of 14 percent of full-time jobs in the past year.
"We have been managing staffing levels across all our resorts; and we have been reviewing all areas of operations for efficiencies," MGM Mirage said Friday in a regulatory filing.
The company said it cut salaried management positions, halted discretionary bonuses, suspended company contributions to 401(k) retirement plans and negotiated changes to union agreements.
MGM Mirage employs 56,000 people, a company spokeswoman said Friday.
TRENTON, N.J.
Investors back merger of rival drugmakers
Shareholders of drugmakers Merck & Co. and Schering-Plough Corp. on Friday both overwhelmingly backed a merger of the New Jersey neighbors.
The acquisition of smaller Schering-Plough allows Merck, the world's eighth-biggest drugmaker by prescription medicine sales, to leapfrog to No. 2 worldwide, just behind Pfizer Inc.
Merck spokeswoman Amy Rose said 99.6 percent of the votes cast by Merck stockholders, or about 1.4 billion shares, supported the $41.1 billion purchase of Schering-Plough.
Hours later, Schering-Plough stockholders also approved the deal almost unanimously, with about 99.1 percent of votes cast, or about 1.26 billion shares.
